This review is regarding a ketamine infusion I had with Ketamine Infusions of Idaho on July 24, 2024. What occurred during that infusion has been the most destabilizing and medically traumatic experience of my life. During the tail end of that infusion, I experienced acute distress. Immediately, I began experiencing extreme neurological hypersensitivity to light, sound, smell, touch, and visual motion. I could not tolerate music. I could not tolerate being touched. Even subtle movement across my skin or within my visual field caused intense distress. Within three hours of the infusion, I had to go to Eastern Idaho Regional Medical Center. Over the following year, I would seek care at five hospitals across Idaho, Utah, and Arizona, in addition to multiple clinics and consultations with clinicians in Washington and Colorado. I would spend a month without hardly any sleep, screaming a writhing. It has taken more than a year to understand what occurred. Two neurologists have since confirmed that my symptoms are consistent with a migraine disorder triggered by acute neurological distress. Individuals who develop daily persistent migraines often know the exact moment the condition begins. I do as well. It began during the ketamine infusion. I am not claiming ketamine alone caused this. I was already under psychological stress, which is why I sought treatment. However, ketamine was the final and immediate catalyst. Without that infusion, this migraine likely would not have been triggered at that time, or perhaps at all. For over 18 months, I lived in a state of extreme sensory hypersensitivity. I could not cook due to smell sensitivity. I could not watch television due to visual motion. I could not listen to music. I could not tolerate affectionate touch from my partner. How isolating! Only recently have these symptoms begun to lift, allowing me to experience music again (just two weeks ago) for the first time since July 2024. I don't know how long this reprieve will last. When I reached out to Christina seeking guidance, I did not receive informed neurological support. The condition was initially suggested to be allodynia. Later, it was suggested that it may have been related to a COVID vaccine. Two neurologists have confirmed that this is not vaccine-related. The symptoms are consistent with migraine physiology triggered by distress. Most concerning to me was that during our conversation, ketamine was repeatedly suggested as the solution... at least five times. There was no acknowledgment that ketamine itself may have contributed as a stressor or catalyst. At no point was there a discussion about the possibility that further ketamine could worsen neurological distress. Ketamine is not a cure-all. It is not without significant neurological risk. Psychedelic experiences can be psychologically and physiologically demanding. While they can be beneficial, they can also overwhelm an already stressed nervous system. Had I been informed that a severely negative neurological response was even a remote possibility, I would not have proceeded with treatment... even if the risk were small. My concern is not ideological. It is about informed consent, risk disclosure, and appropriate aftercare. When adverse neurological events occur, patients deserve recognition, investigation, and referral--- not reflexive recommendation of more of the same intervention. My hope is that someday Ketamine Infusions of Idaho might: Acknowledge that ketamine can act as a detrimental neurological stressor in vulnerable individuals. Improve informed consent to clearly include this risk. Develop a protocol for neurological referral when patients report severe negative reactions following treatment. Avoid defaulting to additional ketamine treatments when a patient presents with possible adverse neurological effects. This experience continues to tax me... every day. I am only now beginning to recover basic sensory tolerances. I am sharing this so that future patients can be informed and better protected.